Chemistry: electrical and wave energy – Processes and products – Electrophoresis or electro-osmosis processes and electrolyte...
Reexamination Certificate
2001-06-14
2004-09-14
Noguerola, Alex (Department: 1753)
Chemistry: electrical and wave energy
Processes and products
Electrophoresis or electro-osmosis processes and electrolyte...
C204S643000
Reexamination Certificate
active
06790330
ABSTRACT:
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates generally to fluidic processing and, more particularly, to methods and apparatuses concerning an integrated fluidic device capable of enriching and isolating a suspect cell subpopulation from a suspension of cells and quantitatively analyzing that subpopulation for marker proteins and mRNAs for the purpose of detection and diagnosis of conditions such as cancer.
2. Description of Related Art
The identification of increasing numbers of genes that influence disease states and the approach of the post-genomic era make evident the need for faster and automated technologies that will allow dissemination of the gains of molecular diagnosis. If sufficiently small, automatic and inexpensive devices can be developed for molecular screening, they would not only revolutionize the diagnosis and prognosis of cancer and other diseases but also would enable molecular methods to be disseminated completely—even to the point of care.
Although some devices such as gene chips and chip embodiments of the polymerase chain reaction (PCR) are beginning to enter use, many of the methods developed so far are labor intensive and are not readily suited to automated, continuous monitoring, or high throughput applications. Clearly, a wide range of enabling technologies is needed before integrated instruments capable of automated sample preparation and molecular analysis of clinical samples become a reality.
SUMMARY OF THE INVENTION
Technology that is the subject of the present addresses issues related to the creation of multiple-use diagnostic systems for combined sample preparation and detection of molecular markers. Disclosed herein are systems, methods, and devices capable of performing fully automated assays. These devices offer the advantages of small size, low sample volume requirements, and the potential for mass production at low cost. Such low-cost systems are applicable to reusable or disposable medical devices.
In one embodiment, such a system may include the following subsystems: (1) a prefilter stage to concentrate suspect cells; (2) a high discrimination separator stage to fractionate cell subpopulations; (3) a stage to burst cells and mobilize molecular components; and (4) a stage for automated analysis of protein and mRNA molecular diagnostic markers.
Important technologies for the development of such a system, and others made apparent by the present disclosure include the following: a prefiltering methodology to trap suspected cancer cells from blood or dispersed lymph node cells; a force balance method that exploits dielectric properties of the suspect cells, and, if needed, their immunomagnetic labeling properties, to fractionate them into a microfluidic isolation and analysis chamber; and a dielectric indexing and manipulation method for carrier beads that, when combined with certain established molecular assay methods, allows for the parallel quantification of multiple molecular markers.
As certain technology disclosed herein builds upon work involving dielectrophoretic trapping, dielectrophoretic field-flow fractionation (DEP-FFF), traveling wave methods, and other work performed by the inventors, the following are hereby specifically incorporated by reference herein in their entirety: U.S. Pat. No. 5,993,630 entitled “Method and Apparatus for Fractionation Using Conventional Dielectrophoresis and Field Flow Fractionation”; U.S. Pat. No. 5,858,192 entitled “Method and Apparatus for Manipulation Using Spiral Electrodes”; U.S. Pat. No. 5,888,370 entitled “Method and Apparatus for Fractionation Using Generalized Dielectrophoresis and Field Flow Fractionation”; U.S. Pat. No. 5,993,632 entitled “Method and Apparatus for Fractionation Using Generalized Dielectrophoresis and Field Flow Fractionation”; U.S. application Ser. No. 09/249,955 filed Feb. 12, 1999 and entitled “Method and Apparatus for Programmable Fluidic Processing” now U.S. Pat. No. 6,294,063; U.S. application Ser. No. 09/395,890 filed Sep. 14, 1999 and entitled “Method and Apparatus for Fractionation Using Generalized Dielectrophoresis and Field Flow Fractionation”, now U.S. Pat. No. 6,287,832; U.S. Provisional Application No. 60/211,757 filed Jun. 14, 2000 and entitled “Method and Apparatus for Combined Magnetophoretic and Dielectrophoretic Manipulation of Analyte Mixtures”; U.S. Provisional Application No. 60/211,515 filed Jun. 14, 2000 and entitled “Dielectrically-Engineered Microparticles”; U.S. Provisional Application No. 60/211,516 filed Jun. 14, 2000 and entitled “Apparatus and Method for Fluid Injection.”
Dielectric indexing represents a new approach to identifying individual molecular tests in a parallel molecular analysis scheme that substitutes dielectric indexing of carrier beads for the spatial indexing used on a gene chip. This new approach allows different subpopulations of beads, each carrying a probe of a different molecular marker, to be identified and manipulated within the carrier medium using a dielectric fingerprint unique to each bead/probe type. The need to immobilize different molecular probes in a tightly specified pattern on a fixed substrate as demanded, for example, by gene chip technology, is thereby eliminated. Mixtures of probes, each probe carried on a separately indexed bead type, may be injected into and flushed from a reusable assay system in order to examine any desired panel of molecular markers.
The use of bead dielectric properties as an indexing parameter not only provides the capability of manipulating beads through dielectrophoresis or another suitable manipulation force, but also offers a new alternative to optical or fluorescent bead indexing methods that might interfere with low light emissions in fluorescent probe assays.
Technology disclosed herein builds upon and synthesizes aspects of many disciplines including field-flow fractionation (physical chemistry), dielectrophoresis and magnetophoresis (physics), microfluidics (mechanical and fluid engineering), microfabrication (photolithography, MEMS and magnetic materials science), control electronics (electrical engineering), antibody and nucleic acid binding and linking (immunology and molecular biology), cell biology (cell culture and cytology), flow cytometry, and oncology.
REFERENCES:
patent: 4001102 (1977-01-01), Batha et al.
patent: 4214981 (1980-07-01), Giddings
patent: 4326934 (1982-04-01), Pohl
patent: 4440638 (1984-04-01), Judy et al.
patent: 5344535 (1994-09-01), Betts et al.
patent: 5454472 (1995-10-01), Benecke et al.
patent: 5489506 (1996-02-01), Crane
patent: 5569367 (1996-10-01), Betts et al.
patent: 5571401 (1996-11-01), Lewis et al.
patent: 5653859 (1997-08-01), Parton et al.
patent: 5683569 (1997-11-01), Chung et al.
patent: 5814200 (1998-09-01), Pethig et al.
patent: 5858192 (1999-01-01), Becker et al.
patent: 5888370 (1999-03-01), Becker et al.
patent: 5965452 (1999-10-01), Kovacs
patent: 5993630 (1999-11-01), Becker et al.
patent: 5993631 (1999-11-01), Parton et al.
patent: 5993632 (1999-11-01), Becker et al.
patent: 6010616 (2000-01-01), Lewis et al.
patent: 6017696 (2000-01-01), Heller
patent: 6093308 (2000-07-01), Lewis et al.
patent: 6099803 (2000-08-01), Ackley et al.
patent: 6113768 (2000-09-01), Fuhr et al.
patent: 6129828 (2000-10-01), Sheldon, III et al.
patent: 6224745 (2001-05-01), Baltruschat
patent: 6225059 (2001-05-01), Ackley et al.
patent: 6287832 (2001-09-01), Becker et al.
patent: 6294063 (2001-09-01), Becker et al.
patent: 0513064 (1992-11-01), None
patent: 0625267 (1994-11-01), None
patent: 0680380 (1995-11-01), None
patent: 0691891 (1996-01-01), None
patent: 0898493 (1999-03-01), None
patent: 2266153 (1993-10-01), None
patent: 1-196566 (1989-08-01), None
patent: 5-126796 (1993-05-01), None
patent: 6-18523 (1994-01-01), None
patent: 474723 (1975-06-01), None
patent: WO 90/08759 (1990-08-01), None
patent: WO 91/11262 (1991-08-01), None
patent: WO 93/16383 (1993-08-01), None
patent: WO 93/20927 (1993-10-01), None
patent: WO 94/16821 (1994-08-01), None
patent: WO 94/22583 (1994-10-01), None
patent: WO 95/1381
Becker Frederick F.
Gascoyne Peter
Vykoukal Jody V.
Board of Regents , The University of Texas System
Fulbright & Jaworski LLP
Noguerola Alex
LandOfFree
Systems and methods for cell subpopulation analysis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Systems and methods for cell subpopulation analysis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Systems and methods for cell subpopulation analysis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3238249